Bexion Partners with Molecular Targeting Technologies on Novel Cancer Imaging Agent

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI) announced today that they have agreed to collaborate with Bexion Pharmaceuticals, LLC (Bexion) to develop a novel nanovesicle for molecular imaging of tumors.